Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,828,181
  • Shares Outstanding, K 66,351
  • Annual Sales, $ 20 K
  • Annual Income, $ -194,590 K
  • 60-Month Beta 1.00
  • Price/Sales 282,185.25
  • Price/Cash Flow N/A
  • Price/Book 12.84
Trade BEAM with:

Options Overview

Details
  • Implied Volatility 76.27%
  • Historical Volatility 54.90%
  • IV Percentile 18%
  • IV Rank 16.63%
  • IV High 129.39% on 01/15/21
  • IV Low 65.67% on 11/25/20
  • Put/Call Vol Ratio 1.04
  • Today's Volume 784
  • Volume Avg (30-Day) 323
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 3,327
  • Open Int (30-Day) 2,942

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.72
  • Number of Estimates 5
  • High Estimate -0.19
  • Low Estimate -0.99
  • Prior Year -0.69
  • Growth Rate Est. (year over year) -4.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.81 +7.41%
on 08/19/21
116.91 -11.98%
on 09/07/21
+0.82 (+0.80%)
since 08/17/21
3-Month
82.37 +24.94%
on 07/27/21
138.52 -25.71%
on 07/02/21
+17.91 (+21.07%)
since 06/17/21
52-Week
22.13 +365.02%
on 10/02/20
138.52 -25.71%
on 07/02/21
+74.52 (+262.49%)
since 09/17/20

Most Recent Stories

More News
Beam Therapeutics to Participate in the 2021 Wells Fargo Virtual Healthcare Conference

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in...

BEAM : 102.91 (+0.82%)
Editas (EDIT) Up More Than 70% in Past 3 Months: Here's Why

Editas' (EDIT) lead candidate, EDIT-101, which employs CRISPR gene editing to treat LCA10, holds potential. The company is also developing EDIT-301 for treating hematologic diseases.

BEAM : 102.91 (+0.82%)
EDIT : 63.20 (+3.61%)
NTLA : 157.29 (+2.24%)
CRSP : 124.52 (+6.05%)
How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

BEAM : 102.91 (+0.82%)
EDIT : 63.20 (+3.61%)
PBE : 77.70 (+1.38%)
NTLA : 157.29 (+2.24%)
CRSP : 124.52 (+6.05%)
ARKG : 83.93 (+3.01%)
GNOM : 24.22 (+3.15%)
IDNA : 55.20 (+1.56%)
Company News for Aug 11, 2021

Companies In The News Are: VSH, SYY, NOVT, BEAM

SYY : 76.09 (-0.87%)
BEAM : 102.91 (+0.82%)
VSH : 20.47 (-2.62%)
NOVT : 153.90 (-0.14%)
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates

Beam Therapeutics Inc. (BEAM) delivered earnings and revenue surprises of -63.79% and -99.98%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?...

BEAM : 102.91 (+0.82%)
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial Results

Company On-track to Submit First IND for BEAM-101 in the Second Half of 2021

BEAM : 102.91 (+0.82%)
S&P, NASDAQ Set New Highs While Waiting for Jobs Report

S&P, NASDAQ Set New Highs While Waiting for Jobs Report

RXT : 14.85 (-1.79%)
MTRN : 71.14 (+1.35%)
CRSP : 124.52 (+6.05%)
BEAM : 102.91 (+0.82%)
APLS : 34.21 (+0.62%)
NTLA : 157.29 (+2.24%)
ONCT : 4.24 (+1.44%)
EDIT : 63.20 (+3.61%)
PACB : 29.44 (+6.71%)
CCRN : 20.82 (+1.02%)
ALTO : 4.82 (-1.83%)
Beam Therapeutics Inc. (BEAM) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Beam Therapeutics Inc. (BEAM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BEAM : 102.91 (+0.82%)
Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Giuseppe Ciaramella, Ph.D., president and chief scientific...

BEAM : 102.91 (+0.82%)
Thinking about buying stock in Covanta, Vertex Energy, OncoSec Medical, Energous Corp, or Beam Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CVA, VTNR, ONCS, WATT, and BEAM.

ONCS : 2.19 (+9.50%)
VTNR : 6.09 (-1.77%)
WATT : 2.27 (+6.57%)
BEAM : 102.91 (+0.82%)
CVA : 20.11 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 113.27
2nd Resistance Point 108.50
1st Resistance Point 105.71
Last Price 102.91
1st Support Level 98.14
2nd Support Level 93.37
3rd Support Level 90.57

See More

52-Week High 138.52
Last Price 102.91
Fibonacci 61.8% 94.06
Fibonacci 50% 80.33
Fibonacci 38.2% 66.59
52-Week Low 22.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar